Arrive Health (formerly RxRevu) recently acquired a suite of technology developed at UPMC. The technology suite includes an AI-powered chatbot and customer relationship management platform, both designed to support improved medication adherence and prescription capture rates.
The company, which is called Infectious Disease (ID) Connect, aims to virtually connect UPMC infectious disease specialists to other hospitals.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Rasu Shrestha, UPMC's chief innovation officer and executive vice president of UPMC Enterprises, will join Atrium Health as its chief strategy officer in February 2019.
Though terms of the deal were not disclosed, the organizations said the combined company will serve almost 100 facilities in 14 states.
The Tus Science & Technology Service Group, an enterprise group in China, led the Series A round with participation from the commercialization arm of University of Pittsburgh Medical Center — UPMC Enterprises.
The president of UPMC's venture arm and it's innovation chief were among panelists explaining the benefits of having a hospital as an investor while asking for help from startups to transform the customer experience in healthcare.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Microsoft chose UPMC Enterprises as its initial innovation partner for Healthcare NExT as the Redmond Empire takes aim at the growing influence of IBM Watson Health, Salesforce, Apple's ResearchKit and other tech heavyweights.
UPMC Enterprises is the innovation and commercialization arm of the University of Pittsburgh Medical Center and it has launched about 60 healthcare companies to date.
Cernostics is part of the wave of oncology that looks at cancer at the tissue and cellular level instead of focusing on the location of the tumor — lung, stomach, pancreas.